SARTORIUS STEDIM BIOTECH

Corporation with Board of Directors
Aubagne, France
Closing date: December 31
Date of the Next Annual General Meeting: March 25, 2025
- CAC NEXT 20 ,
- Eurozone 300 ,
- SBF 120 ,
- STOXX®Europe 600 ,
- CAC All - Tradable
- E&B Pharmaceuticals & Biotechnology
- Euro Stoxx Sustainability
- E&B SBF 80 ,
- CDP Climate Change (C)

Ethics & Boards Databank reserved for subscribers

Governance leadership structure

8 voting members without any non-voting

Directors
average seniority 9.5 years
10.7 years for elected by shareholders

Directors
average age - years
61.8 years for elected by shareholders

Chair and CEO roles are separated:
Is the Nomination committee Chair independent?	Yes
Is there a 2/3 majority of independent Directors in the Audit Committee?	Yes

30.4 % Percentage of variable remunerations in 2023 Global compensation

Board of Directors